Jazz Pharmaceuticals plc·4

Mar 9, 5:56 PM ET

Larkin Finbar 4

4 · Jazz Pharmaceuticals plc · Filed Mar 9, 2022

Insider Transaction Report

Form 4
Period: 2022-03-03
Larkin Finbar
SVP, Technical Operations
Transactions
  • Award

    Ordinary Shares

    [F1][F2]
    2022-03-03+4,62121,209 total
Footnotes (2)
  • [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2022, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
  • [F2]Includes 120 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2021.
Signature
By: /s/Adam Guttmann, as attorney in fact For: Finbar Larkin|2022-03-09

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT